0001437749-20-018786.txt : 20200925 0001437749-20-018786.hdr.sgml : 20200925 20200826210136 ACCESSION NUMBER: 0001437749-20-018786 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sun BioPharma, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 CORRESP 1 filename1.htm snbp20200826_corresp.htm

 

Sun BioPharma, Inc.

712 Vista Blvd, Suite 305

Waconia, MN 55387

 

August 26, 2020

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance
Office of Life Sciences

100 F. Street, N.E.

Washington, D.C. 20549
Attn: Abby Adams

 

Re:

Sun BioPharma, Inc.
Registration Statement on Form S-1
Filed July 2, 2020
File No. 333-239661

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Sun BioPharma, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement (the “Registration Statement”) be accelerated so that it will be declared effective at 5:00 p.m. (EDT) on August 27, 2020, or as soon thereafter as possible. The Company hereby acknowledges its responsibilities under the Securities Act of 1933, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

 

Please direct any questions or comments concerning this request to Joshua L. Colburn of Faegre Drinker Biddle & Reath LLP, counsel to the Company, at +1 (612) 766-8946.

 

 

Sincerely,

 

SUN BIOPHARMA, INC.

 

/s/ Susan Horvath                                                    

Susan Horvath

Vice President of Finance, Chief Financial Officer,

Treasurer and Secretary